Symbiotic relationship of pharmacogenetics and drugs of abuse
Journal Title: The AAPS Journal - Year 2006, Vol 8, Issue 1
Abstract
Pharmacogenetics/pharmacogenomics is the study of how genetic variation affects pharmacology, the use of drugs to treat disease. When drug responses are predicted in advance, it is easier to tailor medications to different diseases and individuals. Pharmacogenetics provides the tools required to identify genetic predictors of probable drug response, drug efficacy, and drug-induced adverse events—identifications that would ideally precede treatment decisions. Drug abuse and addiction genetic data have advanced the field of pharmacogenetics in general. Although major findings have emerged, pharmacotherapy remains hindered by issues such as adverse events, time lag to drug efficacy, and heterogeneity of the disorders being treated. The sequencing of the human genome and high-throughput technologies are enabling pharmacogenetics to have greater influence on treatment approaches. This review highlights key studies and identifies important genes in drug abuse pharmacogenetics that provide a basis for better diagnosis and treatment of drug abuse disorders.
Authors and Affiliations
Joni L. Rutter
Keywords
Related Articles
- EP ID EP681652
- DOI 10.1208/aapsj080121
- Views 72
- Downloads 0
Introduction: Pharmaceutics and drug delivery
Novel Redox-Responsive Amphiphilic Copolymer Micelles for Drug Delivery: Synthesis and Characterization
A novel redox-responsive amphiphilic polymer was synthesized with bioreductive trimethyl-locked quinone propionic acid for a potential triggered drug delivery application. The aim of this study was to synthesize and char...
Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics
This paper represents the consensus views of a cross-section of companies and organizations from the USA and Canada regarding the validation and application of liquid chromatography tandem mass spectrometry (LC-MS/MS) me...
Characterization of Microchannels Created by Metal Microneedles: Formation and Closure
Transdermal delivery of therapeutic agents for cosmetic therapy is limited to small and lipophilic molecules by the stratum corneum barrier. Microneedle technology overcomes this barrier and offers a minimally invasive a...
Measurement of Subvisible Particulates in Lyophilised Erwinia chrysanthemil -asparaginase and Relationship with Clinical Experience
In order to generate further characterisation data for the lyophilised product Erwinia chrysanthemil -asparaginase, reconstituted drug product (DP; marketed as Erwinase or Erwinaze) was analysed for subvisible (2–...